A CLINICAL ACCOUNT OF SHORT STATURE IN PAKISTANI CHILDREN AND ADOLESCENTS PRESENTED AT AN ENDOCRINE CENTER IN KARACHI.

Main Article Content

Ihsan Bashir
Wajid Ali
Musarrat Riaz
Saima Askari
Urooj Lal Rehman
Zaheeruddin

Abstract

Background: Short stature in children is a multifactorial condition influenced by genetic, hormonal, nutritional, and environmental factors. Differentiating between normal growth variants and pathological causes is essential for timely intervention. In resource-limited settings, such as Pakistan, understanding local patterns of short stature helps guide cost-effective diagnostic strategies and avoid unnecessary therapies. This study investigates the causes and contributing factors of short stature among pediatric patients evaluated at a tertiary endocrine care center in Karachi.


Objective: To evaluate various etiologies of short stature in children and adolescents presenting at a tertiary care endocrine center.


Methods: A retrospective cohort study was conducted at the Baqai Institute of Diabetology and Endocrinology, Baqai Medical University, Karachi. Medical records from the past five years were reviewed. Children aged 2 to 20 years with complaints of short stature were included. Data collected included age, gender, weight, height, BMI, mid-parental height, birth and feeding history, developmental milestones, and history of chronic illness. Investigations included IGF-1 levels, bone age assessment, thyroid function, vitamin D levels, and anti-tissue transglutaminase antibodies. Data were recorded using a standardized proforma and analyzed using SPSS version 26.


Results: Among 120 participants (56 males, 64 females), the mean age was 13.23 ± 3.18 years. Mean weight was 38.2 ± 13.85 kg, height 136.38 ± 16.19 cm, and BMI 20.12 ± 4.63 kg/m². Mid-parental height averaged 160.2 ± 8.46 cm. IGF-1 levels were 279.38 ± 69.81 ng/mL and bone age was significantly lower in males than females (12.39 ± 3.25 vs. 13.58 ± 3.20 years, p = 0.047). Normal growth variation was identified in 33.3% of cases, followed by constitutional growth delay (22.5%) and idiopathic short stature (18.3%). Significant positive correlations with height SD were found for IGF-1 (p = 0.045), hemoglobin (p = 0.007), and birth weight (p = 0.002).


Conclusion: Normal growth variation was the most prevalent cause of short stature, followed by constitutional growth delay and idiopathic short stature. These findings highlight the importance of differentiating physiological growth patterns from pathological conditions to avoid overtreatment.

Article Details

Section
Articles
Author Biographies

Ihsan Bashir, Baqai Institute of Diabetology & Endocrinology, Karachi, Pakistan.

Fellow Endocrinology, Baqai Institute of Diabetology & Endocrinology, Karachi, Pakistan.

Wajid Ali, Jinnah Postgraduate Medical Center, Karachi, Pakistan.

Assistant Professor Endocrinology, Jinnah Postgraduate Medical Center, Karachi, Pakistan.

Musarrat Riaz, Dow University of Health Sciences, Karachi, Pakistan.

Professor of Endocrinology, National Institute of Diabetes and Endocrinology, Dow University of Health Sciences, Karachi, Pakistan.

Saima Askari, Baqai Medical University, Karachi, Pakistan.

Assistant Professor, Baqai Institute of Diabetology & Endocrinology, Baqai Medical University, Karachi, Pakistan.

Urooj Lal Rehman, Jinnah Postgraduate Medical University, Karachi, Pakistan.

Associate Professor of Endocrinology, Jinnah Postgraduate Medical University, Karachi, Pakistan.

Zaheeruddin, Baqai Institute of Diabetology & Endocrinology, Karachi, Pakistan.

Consultant Physician Diabetologist and Endocrinologist, Baqai Institute of Diabetology & Endocrinology, Karachi, Pakistan.

References

Patel R, Bajpai A. Evaluation of short stature in children and adolescents. Indian Journal of Pediatrics. 2021 Dec;88(12):1196-202.

Mertens A, Benjamin-Chung J, Colford Jr JM, Coyle J, van der Laan MJ, Hubbard AE, et al. Causes and consequences of child growth failure in low-and middle-income countries. MedRxiv. 2020 Jun 11:2020-06.

Polidori N, Castorani V, Mohn A, Chiarelli F. Deciphering short stature in children. Annals of pediatric endocrinology & metabolism. 2020 Jun;25(2):69.

Halas JG, Grimberg A. Dilemmas of growth hormone treatment for GH deficiency and idiopathic short stature: defining, distinguishing, and deciding. Minerva pediatrica. 2020 Jun;72(3):206.

Ali A. Current status of malnutrition and stunting in Pakistani children: what needs to be done? Journal of the American College of Nutrition. 2021 Feb 17;40(2):180-92.

Karim MR, Shamaly KJ, Tithi BB, Akter R, Jahan I, Begum S. Etiology of short stature in children attending pediatric endocrinology clinic of a tertiary care hospital in Bangladesh. Int J Contemp Pediatr. 2020 Feb;7(2):363-8.

Iqbal HU, Ibrahim M, Shabbir K, Shaukat Z. The Etiological Spectrum OF Short Stature among Children Attending Endocrine Clinic at Tertiary Care Hospital. Growth. 2024;11(7.9):0-935.

Abdullah S, Ch A, Zreik Y. Etiological Classification of Short Stature in Children over 5 Years Old. International Journal of Pediatric Research. 2022;8(2):8-98.

Essaddam L, Kallali W, Cherifi E, Guedri R, Mattoussi N, Fitouri Z, et al. Characteristics and etiologies of short stature in children: Experience of an endocrine clinic in a Tunisian tertiary care hospital. International Journal of Pediatrics and Adolescent Medicine. 2020 Jun 1;7(2):74-7.

Durá-Travé T, San Martín-García I, Gallinas-Victoriano F, Chueca-Guindulain MJ, Berrade-Zubiri S. Catch-up growth and associated factors in very low birth weight infants. Anales de Pediatría (English Edition). 2020 Nov 1;93(5):282-8.

Bamba V, Kanakatti Shankar R. Approach to the Patient: Safety of Growth Hormone Replacement in Children and Adolescents. J Clin Endocrinol Metab. 2022;107(3):847-61.

Cohen LE, Rogol AD. Children With Idiopathic Short Stature: An Expanding Role for Genetic Investigation in Their Medical Evaluation. Endocr Pract. 2024;30(7):679-86.

Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, et al. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. J Clin Endocrinol Metab. 2022;107(7):e2717-e28.

Patel R, Bajpai A. Evaluation of Short Stature in Children and Adolescents. Indian J Pediatr. 2021;88(12):1196-202.

Grimberg A, Hawkes CP. Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology. J Clin Endocrinol Metab. 2024;109(2):e442-e54.

Zhou Y, Wei X, Cheng B. Intrasellar Cephalocele. World Neurosurg. 2021;148:13-4.

Zadik Z, Zelinska N, Iotova V, Skorodok Y, Malievsky O, Mauras N, et al. An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment. J Pediatr Endocrinol Metab. 2023;36(3):261-9.

Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibáñez L, Carlsson M, et al. Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort. J Clin Endocrinol Metab. 2022;107(12):3287-301.

Ranke MB. Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency. Front Endocrinol (Lausanne). 2021;12:720419.

Wit JM. Should Skeletal Maturation Be Manipulated for Extra Height Gain? Front Endocrinol (Lausanne). 2021;12:812196.